TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep)
10.1158/1078-0432.CCR-12-0036
Saved in:
Main Authors: | Cheng, L.L., Itahana, Y., Lei, Z.D., Chia, N.-Y., Wu, Y., Yu, Y., Zhang, S.L., Thike, A.A., Pandey, A., Rozen, S., Voorhoeve, P.M., Yu, Q., Tan, P.H., Bay, B.H., Itahana, K., Tan, P. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110327 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
P53 GENOMIC STATUS REGULATES SENSITIVITY OF GASTRIC CANCER CELLS TO THE HISTONE METHYLATION INHIBITOR 3-DEAZANEPLANOCIN A (DZNEP)
by: CHENG LAI LING
Published: (2012) -
Cell-based proteome profiling using an affinity-based probe (AfBP) derived from 3-deazaneplanocin A (DzNep)
by: Tam, E.K.W., et al.
Published: (2014) -
Functional characterization of D9, a novel deazaneplanocin a (DZNep) analog, in targeting acute myeloid leukemia (AML)
by: Jiang, Xia, et al.
Published: (2015) -
Transglutaminase 2 contributes to a TP53- induced autophagy program to prevent oncogenic transformation
by: Yeo S.Y., et al.
Published: (2020) -
PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER
by: JIANG XIA
Published: (2014)